Skip to content

Clinical trials

Recruiting Phase 1/2 Central Nervous System Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 1/2 Status: Recruiting Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20211
20222
20231
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Australian & New Zealand Children's Haematology/Oncology Group1
Centre Leon Berard1
Cerenome1
Chirag G. Patil1
Memorial Sloan Kettering Cancer Center1
National Institute of Neurological Disorders and Stroke (NINDS)1
Nationwide Children's Hospital1
Neonc Technologies, Inc.1
Stemline Therapeutics, Inc.1
University Hospital Heidelberg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms10
Glioma5
Brain Neoplasms4
Neoplasms4
Glioblastoma3
Neoplasms by Site2
Recurrence2
Astrocytoma1
Brain Diseases1
Breast Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.